In one paragraphObservational study in Neurology(R) neuroimmunology & neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Gianmarco AbbadessaDipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Napoli, Italia.ORCID 0000-0001-8912-3055 Ugo ChianeseDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Vico L. de Crecchio 7, Naples, Italy.ORCID 0000-0003-2726-1895 Claudia RussoDipartimento di Medicina di Laboratorio e Trasfusionale, Azienda Ospedaliera Universitaria Federico II, Napoli, Italy.ORCID 0000-0001-5869-4445 Giuseppina MieleUOSD Neurologia II, AOU Vanvitelli, Naples, Italy.
Elisabetta MaidaDipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Napoli, Italia.ORCID 0009-0003-6505-0834 Gianmarco EspositoLaboratorio di Immunologia, Istituto degli Endotipi in Oncologia, Metabolismo e Immunologia "G. Salvatore" - Consiglio Nazionale delle Ricerche (IEOMI-CNR), Napoli, Italy.ORCID 0009-0002-9649-9418 Giuseppe RomanoDipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Napoli, Italia.ORCID 0000-0001-7181-5627 Floriana BileDipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Napoli, Italia.
Giacomo LusDipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Napoli, Italia.ORCID 0000-0002-9457-1124 Lucia AltucciDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Vico L. de Crecchio 7, Naples, Italy.ORCID 0000-0002-7312-5387 Claudio ProcacciniLaboratorio di Immunologia, Istituto degli Endotipi in Oncologia, Metabolismo e Immunologia "G. Salvatore" - Consiglio Nazionale delle Ricerche (IEOMI-CNR), Napoli, Italy.ORCID 0000-0002-2184-0442 Giuseppe MatareseTreg Cell Lab, Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli studi di Napoli Federico II, Napoli, Italy.ORCID 0000-0001-9429-0616 Rosaria BenedettiDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Vico L. de Crecchio 7, Naples, Italy.ORCID 0000-0001-5517-5519 Simona BonavitaDipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Napoli, Italia.ORCID 0000-0002-8561-9720 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
BACKGROUND AND
objectivesFc gamma receptor 3A (
methodsIn this observational cohort study, we enrolled people with MS treated with OCR consecutively between May 2022 and August 2025.
resultsIn 101 participants, 500 interinfusion intervals were analyzed. The odds of B-cell repopulation decreased with higher cycle number (odds ratio [OR] per cycle 0.77; 95% CI 0.65-0.91; DISCUSSION: Longer OCR infusion intervals were associated with higher odds of B-cell repopulation. The
Indexed as
Antibodies, Monoclonal, HumanizedB-LymphocytesImmunologic FactorsMultiple SclerosisReceptors, IgGAdultCohort StudiesFemaleHumansKiller Cells, NaturalMaleMiddle AgedAntibodies, Monoclonal, HumanizedFCGR3A protein, humanImmunologic FactorsocrelizumabReceptors, IgG
Identifiers
PMID42579840
PMCPMC13476018
What OpenQuestion holds
Textmetadata
Read underepoch 390